Skip to content

The Effect of Breastfeeding Support Provided Via Video-conferencing

The Effect of Breastfeeding Support Provided Via Video-conferencing on Postpartum Anxiety, Breastfeeding Self-Efficacy and Neonatal Outcomes: A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04929561
Enrollment
78
Registered
2021-06-18
Start date
2020-08-25
Completion date
2021-09-30
Last updated
2021-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorders, Breastfeeding, Neonatal Outcomes

Brief summary

A randomized control trial was made to examine the effects of breastfeeding support given by the video-conferencing method in the early postpartum period on anxiety, breastfeeding self-efficiency, and newborn outcomes.

Interventions

BEHAVIORALVideo-conferencing group

No intervention

Sponsors

Kahramanmaras Sutcu Imam University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Infants; * Born between 37 and 42 weeks * Without severe congenital anomalies Mothers; * A single live birth * Were 18 years of age or over * At least primary school graduate * Did not have a disease that prevents breastfeeding * Had internet access at home or on the phone * Could speak and understand the Turkish language.

Exclusion criteria

* Situations that cause separation of mother and baby * Hospitalization of the baby in intensive care * Inability to answer 3 calls in a video call * They were determined as those who could not be reached during the home visit for the first and second follow

Design outcomes

Primary

MeasureTime frameDescription
The mean postpartum maternal anxiety level (mean ± SD)at 2 weeks and 4 weeks after deliveryThe primary outcome of this study was the mean postpartum maternal anxiety level (mean ± SD) of the mothers at 2 weeks and 4 weeks after delivery. Maternal anxiety level was assessed using the Postpartum Specific Anxiety Scale. The scale comprises 51 items and 4 sub-dimensions. It means that those who score 73 and below on the scale have low postpartum anxiety levels, those who score between 74 and 100 have a medium level, and those who score 101 and above have a high level of anxiety.
The mean breastfeeding self-efficacy levelat 2 weeks and 4 weeks after deliveryThe other main outcome of the study was the mean breastfeeding self-efficacy level (mean ± SD) measured with the Breastfeeding Self-Efficacy Scale Short Form. The scale is likert type and a total score between 14 and 70 is taken from the scale. The higher the score, the higher the breastfeeding self-efficacy.

Secondary

MeasureTime frameDescription
Neonatal outcomes-Need for phototherapyat 2 weeks and 4 weeks after deliveryThe need for phototherapy was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
Neonatal outcomes-Respiratory morbidityat 2 weeks and 4 weeks after deliveryRespiratory morbidity was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
Neonatal outcomes-Newborn weight (g)at 2 weeks and 4 weeks after deliveryNewborn weight (g) was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
Neonatal outcomes-Food intake other than breast milkat 2 weeks and 4 weeks after deliveryFood intake other than breast milk was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
Neonatal outcomes-Neonatal deathat 2 weeks and 4 weeks after deliveryNeonatal death was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
Neonatal outcomes-illness requiring hospitalizationat 2 weeks and 4 weeks after deliveryIllness requiring hospitalization was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery
Neonatal outcomes-Hypoglycemia of the newbornat 2 weeks and 4 weeks after deliveryHypoglycemia of the newborn was evaluated using the Follow-up Form at 2 weeks and 4 weeks after delivery.

Countries

Turkey (Türkiye)

Contacts

Primary ContactDeniz Akyıldız, PhD
denizbtm@gmail.com05069851358
Backup ContactDeniz Akyıldız
denizbtm@gmail.com05069851358

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026